The independent source for health policy research, polling, and news.
9,921 - 9,940 of 15,449 Results
Justice Samuel A. Alito Jr., writing for the majority, favors a tight definition for businesses that can be exempted from the health law's contraceptive mandate. Justice Ruth Bader Ginsburg suggests the consequences may be farther reaching.
The court says closely held corporations may be exempted from the health law's mandate that employer health plans cover certain types of contraception at no cost to the employee.
KHN's Mary Agnes Carey and legal analyst Stuart Taylor discuss Monday's ruling on the health law's contraception mandate, examining what the decision could mean for future challenges to the law.
Critics of the 5-4 decision argued it curbs women's freedom to make appropriate contraceptive decisions.
The University of Utah improved quality and reduced costs by tracking each patient's care.
Patients in rural hospitals often have to wait days to see a psychiatrist. South Carolina is a leader in turning that around.
KHN's consumer columnist says a 90-day delay is allowed by the health law, but employees have other options to get through that time.
Dr. Al Sommer, the former dean of the Johns Hopkins Bloomberg School of Public Health who helped produce a new report on climate change, says changes expected this century could lead to many deaths and a strain on hospitals.
Manufacturers of the essential fluid say they won't be able to catch up with demand until next year.
Caregivers blame Pennsylvania's decision not to expand Medicaid, as well as the continued stigma of seeking such care.
County health officials are scrambling to set up immunization clinics for thousands after 341 cases in Ohio have swept through the Amish communities in the central part of the state.
That state has defined autism behavioral therapy as a type of medical benefit not subject to the mental health parity law, a move that allows insurers more latitude to limit the benefits they offer.
Hospitals and drug makers are waging a pitched battle over the program -- known as 340B -- that requires drug manufacturers to give steep discounts to hospitals that treat a large percentage of poor patients.
© 2026 KFF